Neuroone Medical Technologies (NMTC) Share-based Compensation (2017 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Share-based Compensation came in at $342135.0 in Q1 2026, up 36.76% YoY from $250170.0 in Q1 2025, and down 86.41% on a QoQ basis from $2.5 million in Q4 2025.
Neuroone Medical Technologies (NMTC) Share-based Compensation (2017 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 10 years of Share-based Compensation data on file, last reported at $342135.0 in Q1 2026.
- Quarterly Share-based Compensation rose 36.76% year-over-year to $342135.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 21.75% YoY) and the FY2025 annual result came in at $2.9 million, up 20.88% from the prior year.
- Share-based Compensation fell to $342135.0 in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $2.5 million in Q4 2025 to a low of -$736675.0 in Q3 2023.
- A 5-year average of $357874.8 and a median of $300181.0 in 2022 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation plunged 387.9% — and 2025, when it surged 2150.53%.
- Tracing NMTC's Share-based Compensation over 5 years: stood at $300181.0 in 2022, then gained by 2.82% to $308638.0 in 2023, then sank by 63.74% to $111898.0 in 2024, then surged by 2150.53% to $2.5 million in 2025, then plunged by 86.41% to $342135.0 in 2026.
- The last three Share-based Compensation figures came in at $342135.0 (Q1 2026), $2.5 million (Q4 2025), and $358560.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Neuroone Medical Technologies | 19.89 Mn | 17.84 Mn | 1.18 Mn | 352,777.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 352,777.00 |
| Jun 30, 2026 | 352,777.00 |
| Mar 31, 2026 | 342,135.00 |
| Mar 31, 2026 | 342,135.00 |
| Dec 31, 2025 | 2.52 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Sep 30, 2025 | 358,560.00 |
| Sep 30, 2025 | 358,560.00 |
| Jun 30, 2025 | 316,654.00 |
| Jun 30, 2025 | 316,654.00 |
| Mar 31, 2025 | 250,170.00 |
| Mar 31, 2025 | 250,170.00 |
| Dec 31, 2024 | 111,898.00 |
| Dec 31, 2024 | 111,898.00 |
| Sep 30, 2024 | 340,371.00 |
| Sep 30, 2024 | 340,371.00 |
| Jun 30, 2024 | 338,609.00 |
| Jun 30, 2024 | 338,609.00 |
| Mar 31, 2024 | 356,858.00 |
| Mar 31, 2024 | 356,858.00 |